Yunlong Jia

13PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 13, 2026
LINC01446/miR-338-3p/APEX1 Axis Promotes Ferroptosis Defense and Progression in Esophageal Squamous Cell Carcinoma.

|May 04, 2026
Perioperative Blood Transfusion Impairs Overall Survival Following Radical Resection for Colorectal Cancer: A Propensity Score-Matched Analysis.

|Apr 11, 2025
Aberrant CircTMEM45A Facilitates Inflammatory Progression of Esophageal Squamous Cell Carcinoma through m5C-Mediated NLRP3 Activation.

Lingjiao Meng, Haotian Wu, Jiaxiang Wu

|Dec 20, 2024
Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC.

Yachang Huo, Dan Wang, Shuangning Yang

|Mar 13, 2024
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence.

Shuman Zhen, Yunlong Jia, Yan Zhao

|Jan 04, 2024
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks.

Lingjiao Meng, Haotian Wu, Jiaxiang Wu

Pageof 3

Frequent Collaborators

2 joint publications

Yi Zhang

1 joint publications

Yunlong Jia

1 joint publications

Yueping Liu

1 joint publications

Li Liu